About the Lung Cancer Program
Why Choose BIDMC for Lung Cancer Treatment
Our team of compassionate caregivers includes highly experienced and skilled surgeons and physicians who are thought leaders and innovators in their respective fields. BIDMC physicians are nationally recognized for contributions to the future of thoracic care through their research, clinical trials, publications and society leadership positions, as well as training Harvard Medical School students and providing graduate medical education.
Beth Israel Deaconess Medical Center also participates in the Eastern Cooperative Oncology Group, the Radiation Therapy Oncology Group, and the American College of Surgeons Oncology Group, and is a founding member of the Dana-Farber/Harvard Cancer Center (DF/HCC) — Harvard's National Cancer Institute-designated comprehensive cancer center. We collaborate extensively on clinical trials with the DF/HCC.
The BIDMC Difference
The Lung Cancer Program at BIDMC offers you and your family a number of significant benefits including:
- Exceptional multidisciplinary care
- Renowned expertise in minimally invasive surgery
- Advancements in medical oncology (tumor genotyping and clinical trials) and radiation oncology (CyberKnife stereotactic radiosurgery system)
- Innovations in interventional pulmonology
We excel in applying new minimally invasive approaches to tumors considered to be inoperable. Always, our goal is to improve the quality of your life. Our approach features true multidisciplinary evaluation, shared decision-making, access to state-of-the-art treatments tailored for you, and long-term follow-up care and interest.
As an academic medical center, BIDMC offers key advantages in experience (high volumes of procedures for improved outcomes) and access to the latest research and investigational therapies — but with an uncommon personalized approach. Unlike many others, our program is just the right size to be able to discuss every patient in our weekly multidisciplinary thoracic oncology conference, where you have the input of some 30 specialists, including radiologists and pathologists who display images and slides for team review. Together we reach a consensus recommendation for your cancer treatment.